Component

Oxidized EGCG reaction products, unresolved mixture

Study-scoped entity; inspect species, exposure, model and limitations on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Remodeling of the tested mature amyloid preparations depended on EGCG autooxidation.

    Experimental context and source evidence
    experimental_model
    Amyloid-beta 1–40 and IAPP/Sup35 fragment preparations.
    limitations
    Fragment and in-vitro oxidation contexts limit generalization.
    nutrient_topic
    EGCG collection; comparator and shared-pathway records retain their actual intervention. · Epigallocatechin-3-gallate (EGCG)
    plain_language
    The oxidation state helped determine aggregate remodeling.
    primary_references
    Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23611538/ · DOI 10.1021/ja3115696

    EGCG: receptor signaling, metabolism, nutrient interactions and discovery questions (2026-09-18) · lines 380–386

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Amyloid-beta 1–40 and IAPP/Sup35 fragment preparations. · source_derived_draft · unverified_draft

    ## egcg-oxidation-remodel The oxidation state helped determine aggregate remodeling. Remodeling of the tested mature amyloid preparations depended on EGCG autooxidation. Model: Amyloid-beta 1–40 and IAPP/Sup35 fragment preparations. Limitations: Fragment and in-vitro oxidation contexts limit generalization. Evidence access: primary abstract. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23611538/ · DOI 10.1021/ja3115696
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Both oxidized and unoxidized EGCG bound fibrils and prevented Thioflavin T binding.

    Experimental context and source evidence
    experimental_model
    Fibril binding/assay-interference experiments.
    limitations
    Use independent structural and toxicity measurements to distinguish remodeling from dye displacement.
    nutrient_topic
    EGCG collection; comparator and shared-pathway records retain their actual intervention. · Epigallocatechin-3-gallate (EGCG)
    plain_language
    A lower dye signal alone can be mistaken for less amyloid.
    primary_references
    Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23611538/ · DOI 10.1021/ja3115696

    EGCG: receptor signaling, metabolism, nutrient interactions and discovery questions (2026-09-18) · lines 388–394

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Fibril binding/assay-interference experiments. · source_derived_draft · unverified_draft

    ## egcg-tht A lower dye signal alone can be mistaken for less amyloid. Both oxidized and unoxidized EGCG bound fibrils and prevented Thioflavin T binding. Model: Fibril binding/assay-interference experiments. Limitations: Use independent structural and toxicity measurements to distinguish remodeling from dye displacement. Evidence access: primary abstract. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23611538/ · DOI 10.1021/ja3115696
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards